Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis.
Shimony S, Canaani J, Kugler E, Nachmias B, Ram R, Henig I, Frisch A, Ganzel C, Vainstein V, Moshe Y, Aumann S, Yeshurun M, Ofran Y, Raanani P, Wolach O.
Shimony S, et al. Among authors: raanani p.
Ann Hematol. 2022 Sep;101(9):2001-2010. doi: 10.1007/s00277-022-04895-8. Epub 2022 Jun 24.
Ann Hematol. 2022.
PMID: 35739428